The estimated Net Worth of Quentin Mc Cubbin is at least $35.5 Thousand dollars as of 5 July 2022. Quentin Cubbin owns over 17,500 units of Frequency Therapeutics Inc stock worth over $13,473 and over the last 4 years Quentin sold FREQ stock worth over $21,982.
Quentin has made over 5 trades of the Frequency Therapeutics Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Quentin exercised 17,500 units of FREQ stock worth $5,250 on 5 July 2022.
The largest trade Quentin's ever made was exercising 17,500 units of Frequency Therapeutics Inc stock on 5 July 2022 worth over $5,250. On average, Quentin trades about 5,615 units every 46 days since 2021. As of 5 July 2022 Quentin still owns at least 44,909 units of Frequency Therapeutics Inc stock.
You can see the complete history of Quentin Cubbin stock trades at the bottom of the page.
Quentin's mailing address filed with the SEC is 75 HAYDEN AVE, SUITE 300, LEXINGTON, MA, 02421.
Over the last 5 years, insiders at Frequency Therapeutics Inc have traded over $11,017,122 worth of Frequency Therapeutics Inc stock and bought 369,233 units worth $5,339,982 . The most active insiders traders include Joel S Marcus, Robert Langer, and Marc A Cohen. On average, Frequency Therapeutics Inc executives and independent directors trade stock every 11 days with the average trade being worth of $3,858. The most recent stock trade was executed by Richard J. Mitrano on 18 August 2023, trading 464 units of FREQ stock currently worth $269.
frequency therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. through the controlled activation of progenitor cells, frequency enables disease modification without the complexity of genetic engineering. our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the u.s. alone.
Frequency Therapeutics Inc executives and other stock owners filed with the SEC include: